{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-080234","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.078270+00:00","generated_at":"2026-05-20T02:56:21.437860+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Athira shareholders approve reverse stock split at 2025 annual meeting","bullets":["All three Class II director nominees elected: Joseph Edelman, John M. Fluke Jr., Grant Pickering.","Ratification of Ernst & Young as independent auditor approved (26,981,568 for).","Proposal to authorize reverse stock split approved (21,915,867 for, 4,835,818 against).","Board may set final split ratio from 5:1 to 20:1 in its discretion.","Quorum of 71.58% of shares present at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-080234","json":"https://secwatch.observer/filing/0000950170-25-080234.json","markdown":"https://secwatch.observer/filing/0000950170-25-080234.md","text":"https://secwatch.observer/filing/0000950170-25-080234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017025080234/0000950170-25-080234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017025080234/atha-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:56:21.437860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}